Foresee Pharma announces topline results of FP-001 LMIS in prostate cancer
Clinical Research | News | 0 Comment | 22 Feb, 2019
Foresee Pharmaceuticals, a Taiwan and US-based biopharmaceutical company listed on the Taipei Exchange has announced that the topline results of FP-001 LMIS (Leuprolide Mesylate Injectable ...Read more
Enzychem Lifesciences completes Stage 1 patient enrollment in Ph2 CRIOM study
Clinical Research | News | 0 Comment | 22 Feb, 2019
Enzychem Lifesciences, a global biopharmaceutical company headquartered in Seoul, Korea which is dedicated to developing new drugs and APIs (Active Pharmaceutical Ingredients) has announced...Read more
Owlstone Medical partners with Shanghai Renji Hospital
Clinical Research | News | 0 Comment | 22 Feb, 2019
Owlstone Medical, a diagnostics company developing a breathalyzer for applications in early disease detection and precision medicine, and Renji Hospital has announced a collaboration to con...Read more
Sosei Heptares initiates new clinical development programme
Clinical Research | News | 0 Comment | 22 Feb, 2019
Sosei Group Corporation, has announced that the first healthy subject has been dosed with a novel small molecule HTL0030310 in a Phase I clinical study, marking the start of a new in-house ...Read more
Mallinckrodt presents analysis results for Therakos against aGvHD
Clinical Research | News | 0 Comment | 21 Feb, 2019
Mallinckrodt plc, a leading global specialty pharmaceutical company has announced interim analysis results of its company-sponsored, Phase 3, single-arm, open-label, multi-center study asse...Read more
Saniona announces succesful completion of preclinical development of SAN711
Clinical Research | News | 0 Comment | 19 Feb, 2019
Saniona, a biotech company focused on CNS and eating disorders has announced the successful completion of preclinical development of SAN711, for the treatment of chronic itching and neuropa...Read more
Navitas Life Sciences acquires DataCeutics in a $45 MM deal
Clinical Research | News | 0 Comment | 14 Feb, 2019
Navitas Life Sciences, a TAKE Solutions Enterprise has announced that it will be acquiring Life Sciences services player, DataCeutics in North America. The acquisition, as part of the 2021...Read more
Boehringer Ingelheim, IBM to integrate blockchain tech in clinical trials
Clinical Research | News | 0 Comment | 14 Feb, 2019
Boehringer Ingelheim (Canada) Ltd. and IBM Canada have announced at the Healthcare Information and Management Systems Society (HIMSS) conference in Orlando, Florida, their plans to explore ...Read more
Pfizer, Astellas announce results from Ph 3 ARCHES trial in men with mHSPC
Clinical Research | News | 0 Comment | 12 Feb, 2019
Pfizer Inc. and Astellas Pharma Inc. have announced the results from the Phase 3 ARCHES trial in men with metastatic hormone-sensitive prostate cancer (mHSPC). Prostate cancer is considered...Read more
“An efficient approach to clinical trial design will have the greatest impact”
Clinical Research | Opinion | 0 Comment | 06 Feb, 2019
The annual J.P. Morgan Healthcare Conference is the premier investor conference focused exclusively on companies defining the healthcare industry. This is the largest and most informative h...Read more
TLC appoints George Spencer-Green as CMO
Clinical Research | News | 0 Comment | 05 Feb, 2019
Taiwan Liposome Company, a clinical-stage specialty pharmaceutical company dedicated to the development and commercialization of novel nanomedicines designed to target areas of unmet medica...Read more
Eisai, Purdue Pharma announce significant data of ph 3 clinical study
Clinical Research | News | 0 Comment | 04 Feb, 2019
Eisai Co., Ltd. and Purdue Pharma L.P. announced a six-month results from SUNRISE 2, a long-term Phase 3 clinical study evaluating the efficacy and safety of lemborexant, an investigational...Read more
Spero Therapeutics announces initiation of SPR720 Ph 1 Clinical Trial
Clinical Research | News | 0 Comment | 31 Jan, 2019
Spero Therapeutics, a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing novel treatments for multidrug-resistant (MDR) bacter...Read more
Ionis, Roche initiates pivotal study of RG6042 for Huntington's disease
Clinical Research | News | 0 Comment | 30 Jan, 2019
Ionis Pharma, Inc. the leader in antisense therapeutics, has announced that its partner Roche has enrolled the first patient in a pivotal study of RG6042 (IONIS-HTTRx) for people livin...Read more
NIAID-sponsored trial of Ebola vaccines begins at Cincinnati Children's Hospital
Clinical Research | News | 0 Comment | 29 Jan, 2019
A Phase 1 clinical trial of investigational vaccines intended to protect against Zaire ebolavirus (Ebola) is underway at Cincinnati Children's Hospital Medical Center in the United Sta...Read more
Dicerna announces start of Ph1 clinical trial of DCR-HBVS
Clinical Research | News | 0 Comment | 29 Jan, 2019
Dicerna Pharmaceuticals, a leading developer of RNA interference (RNAi) therapeutics, today announced the dosing of the first human volunteer in its Phase 1 clinical trial of DCR-HBVS, the ...Read more
OliX announces clinical candidate for Geographic Atrophy treatment
Clinical Research | News | 0 Comment | 29 Jan, 2019
OliX Pharmaceuticals, Inc., a leading developer of RNAi therapeutics, has announced the nomination of OLX10020 as a clinical candidate for the treatment of Geographic Atrophy (GA), which is...Read more
Translate Bio announces FDA clinical hold on IND
Clinical Research | News | 0 Comment | 23 Jan, 2019
Translate Bio, a clinical-stage messenger RNA (mRNA) therapeutics company developing a new class of potentially transformative medicines to treat diseases caused by protein or gene dysfunct...Read more